Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report
Clinical Case Reports May 28, 2024 Harman Chopra, Tim Furnish, Monica Verduzco-Gutierrez et al. 6 citations
A 41-year-old fully vaccinated woman with Long-COVID syndrome experienced significant symptom relief after self-medicating with psilocybin and MDMA. Long-COVID, a condition persisting after the acute phase of COVID-19, currently lacks effective holistic treatments. This case suggests potential benefit from these substances, but further research is required to evaluate their safety and efficacy.